David J. Wambeke Dia Medica Therapeutics Inc. (DMAC) insider trading activity

DMAC Quotes by TradingView

David J. Wambeke is Chief Business Officer of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 527,114 shares of DMAC, which is worth approximately $2.32 Million. The most recent transaction as insider was on Nov 16, 2023, when has been sold 20,000 shares (Voting Common Shares, no par value per share) at a price of $2.46 per share, resulting in proceeds of $49,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 527K
0% 3M change
3.94% 12M change
Total Value Held $2.32 Million

David J. Wambeke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2023
BUY
Open market or private purchase
$49,200 $2.46 p/Share
20,000 Added 3.66%
527,114 Voting Common Shares, ...
Jun 23 2023
BUY
Open market or private purchase
$150,003 $3.91 p/Share
38,364 Added 7.03%
507,114 Voting Common Shares, ...
Apr 10 2023
BUY
Open market or private purchase
$750,000 $1.6 p/Share
468,750 Added 50.0%
468,750 Voting Common Shares, ...
DJW

David J. Wambeke

Chief Business Officer
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMAC